Search results
Pioneering studies show promise in sequencing a baby’s genome at birth
Washington Post· 5 days agoTiffany King had given birth to her daughter, Fern, a little more than a month earlier and was back...
Giant-pawed kitten bullies every animal in the house: "Chosen violence"
Newsweek· 6 days agoMittens, named for his extra toes that give him unusually large paws, lives in Canada with owner...
Study: Celebrex reduces risk of colon cancer recurrence — and more
WGN TV Chicago· 2 days agoMedical Watch for June 19. Study: Celebrex reduces risk of colon cancer recurrence A new use for a...
Check Out An Exclusive Excerpt From Titan's MARVEL'S AVENGERS: THE FIRST 60 YEARS
ComicBookMovie.com· 2 days agoNext month, Titan will publish a celebration of Earth's Mightiest Heroes with Marvel's Avengers: The...
Researchers provide a review and update on therapy of gastrointestinal tract tumors
Medical Xpress· 3 days agoGastrointestinal (GI) cancers, encompassing esophageal, gastric, small bowel, and colorectal...
Rapid test of cerebrospinal fluid found to decrease time to diagnosis for brain tumors
Medical Xpress· 3 days agoThe team evaluated the technique known as TetRS (Targeted Rapid Sequencing) among 70 patients...
Cellular Fountain of Youth: New T-Cell Discovery Rewrites the Rules of Aging
SciTechDaily· 3 days agoResearchers at St. Jude Children’s Research Hospital and the University of Minnesota have discovered...
New Braunfels team paddleboarding from Bahamas to Florida to raise money for cystic fibrosis
The New Braunfels Herald-Zeitung· 3 days agoRyan Barry and his friends navigate a stand-up paddleboard at Hinman Island Park in New Braunfels....
Study identifies mechanism behind glioblastoma's immunotherapy resistance
Medical Xpress· 1 day agoThe cells of a rare, deadly cancer are resistant to immunotherapy. Now researchers may have found the cause, paving the way for a new type of treatment.
FDA expands approval of first gene therapy for rare form of muscular dystrophy – KION546
KION 46 Salinas· 1 day agoElevidys, from the biotech company Sarepta Therapeutics – was approved to treat only children ages 4...